[AIDS: the beginning of a catastrophe?]

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Leukemia·2018

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Leukemia·2017

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

Leukemia·2016

[75-year old female with progressive idiopathic lung fibrosis].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Resistant hypertension despite nine different antihypertensive drugs?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Medizinische Klinik (Munich, Germany : 1983)·2011

HYDRAULIC ANKLE FOOT ORTHOSIS EMULATOR FOR CHILDREN WITH CEREBRAL PALSY.

Proceedings of the ASME/BATH Symposium on Fluid Power and Motion Control. ASME/BATH Symposium on Fluid Power and Motion Control·2026

Comparative outcomes of anatomic and reverse total shoulder arthroplasty for rotator cuff-intact glenohumeral osteoarthritis: a propensity score-matched, age-stratified exploratory analysis.

Journal of shoulder and elbow arthroplasty·2026

Continuous clinical and radiological follow-up of isainlay reverse shoulder prostheses: results from the isa registry with a minimum of 1-year follow-up.

Journal of shoulder and elbow arthroplasty·2026

Predictive factors for return to work after shoulder arthroplasty.

Journal of shoulder and elbow arthroplasty·2026

Modified Postoperative Rehabilitation Including Dynamic Posterior Cruciate Ligament Brace to Reduce Recurrence of Posterior Tibial Translation After Posterior Cruciate Ligament Reconstruction: A Retrospective Comparative Cohort Study.

Orthopaedic journal of sports medicine·2026

Femoral Shortening Osteotomy Techniques in Total Hip Arthroplasty for Hartofilakidis Type C Developmental Hip Dysplasia: A 25-Year Single-Surgeon Series.

The Journal of arthroplasty·2026

Related Experiment Videos

[AIDS: the beginning of a catastrophe?]

Related Concept Videos

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

[75-year old female with progressive idiopathic lung fibrosis].

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

[Resistant hypertension despite nine different antihypertensive drugs?].

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

HYDRAULIC ANKLE FOOT ORTHOSIS EMULATOR FOR CHILDREN WITH CEREBRAL PALSY.

Comparative outcomes of anatomic and reverse total shoulder arthroplasty for rotator cuff-intact glenohumeral osteoarthritis: a propensity score-matched, age-stratified exploratory analysis.

Continuous clinical and radiological follow-up of isainlay reverse shoulder prostheses: results from the isa registry with a minimum of 1-year follow-up.

Predictive factors for return to work after shoulder arthroplasty.

Modified Postoperative Rehabilitation Including Dynamic Posterior Cruciate Ligament Brace to Reduce Recurrence of Posterior Tibial Translation After Posterior Cruciate Ligament Reconstruction: A Retrospective Comparative Cohort Study.

Femoral Shortening Osteotomy Techniques in Total Hip Arthroplasty for Hartofilakidis Type C Developmental Hip Dysplasia: A 25-Year Single-Surgeon Series.

Related Experiment Videos

[AIDS: the beginning of a catastrophe?]

Related Concept Videos

Related Articles